Spear Bio

Spear Bio is a biotechnology company developing ultra-sensitive protein biomarker measurement technology. Their proprietary SPEAR technology uses standard qPCR equipment to precisely measure proteins at the attomolar level, enabling advancements in protein research and early disease diagnostics. This technology offers significant advantages over conventional methods by requiring much smaller sample volumes.


Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $45M

Date: 29-Jul-2024

Investors: Foresite Capital, Bio-Techne Corporation, Maverick Ventures, Yonjin Capital, CDH Investments

Markets: Biotechnology, Diagnostics, Protein Research, Health Care, Health Diagnostics

HQ: Woburn, Massachusetts, United States

Founded: 2021

Website: https://www.spear.bio

LinkedIn: https://www.linkedin.com/company/spearbio

Twitter: https://twitter.com/spearbio

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/spear-bio

Pitchbook: https://pitchbook.com/profiles/company/463540-33


Leave a Comment